EUVIMEDEUVIMED entdecken
LeserbriefFallbericht

Anti‐TIF1‐γ‐associated dermatomyositis associated with recurrent metastatic triple‐negative breast cancer: Dramatic clinical response to sacituzumab govitecan

Wei-Yao Wang iD, Chin-Yu Lee, Stephen Chu-Sung Hu

JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2024

DOI: 10.1111/ddg.15399 ↗

Kurz gefasst

Leserbrief in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2024. Verfasst von Wei-Yao Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Antibodies, Monoclonal, Humanized, Dermatomyositis. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsAntibodies, Monoclonal, HumanizedDermatomyositisHumansFemaleTranscription FactorsCamptothecinNeoplasm Recurrence, LocalMiddle AgedTreatment OutcomeImmunoconjugates

Stichwörter der Autor:innen

Anti‐transcriptional intermediary factor 1 gamma antibodybreast cancerdermatomyositisparaneoplastic syndromesacituzumab govitecan

Substanzen

Antibodies, Monoclonal, Humanizedsacituzumab govitecanTRIM33 protein, humanTranscription FactorsCamptothecinImmunoconjugates

Autor:innen und Institutionen

  • Department of Dermatology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
  • Department of Dermatology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Department of Dermatology, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan.

ORCID-Profile: Wei-Yao Wang

Zitieren

APA

Wang, W. Y., Lee, C. Y., & Hu, S. C. (2024). Anti‐TIF1‐γ‐associated dermatomyositis associated with recurrent metastatic triple‐negative breast cancer: Dramatic clinical response to sacituzumab govitecan. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/ddg.15399

Vancouver

Wang WY, Lee CY, Hu SC. Anti‐TIF1‐γ‐associated dermatomyositis associated with recurrent metastatic triple‐negative breast cancer: Dramatic clinical response to sacituzumab govitecan. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2024. doi:10.1111/ddg.15399

BibTeX
@article{Wang2024,
  author = {Wang, Wei-Yao and Lee, Chin-Yu and Hu, Stephen Chu-Sung},
  title = {Anti‐TIF1‐γ‐associated dermatomyositis associated with recurrent metastatic triple‐negative breast cancer: Dramatic clinical response to sacituzumab govitecan},
  journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
  year = {2024},
  doi = {10.1111/ddg.15399}
}
Kostenlos starten →